{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:44:17Z","timestamp":1793148257385,"version":"4.5.0"},"reference-count":221,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T00:00:00Z","timestamp":1727308800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jaut.2024.103323","type":"journal-article","created":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T07:50:46Z","timestamp":1728114646000},"page":"103323","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Extrapulmonary sarcoidosis"],"prefix":"10.1016","volume":"149","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1096-0596","authenticated-orcid":false,"given":"Paolo","family":"Spagnolo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasileios","family":"Kouranos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Singh-Curry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"El Jammal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misha","family":"Rosenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2024.103323_bib1","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMra2101555","article-title":"Challenges of sarcoidosis and its management","volume":"385","author":"Drent","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2024.103323_bib2","first-page":"61","article-title":"The frequency of sarcoidosis in Finland and Hokkaido, Japan. A comparative epidemiological study","volume":"12","author":"Pietinalho","year":"1995","journal-title":"Sarcoidosis"},{"key":"10.1016\/j.jaut.2024.103323_bib3","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1164\/ajrccm.164.10.2104046","article-title":"Clinical characteristics of patients in a case control study of sarcoidosis","volume":"164","author":"Baughman","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jaut.2024.103323_bib4","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/oxfordjournals.aje.a009096","article-title":"Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization","volume":"145","author":"Rybicki","year":"1997","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.jaut.2024.103323_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.100966","article-title":"Extrapulmonary sarcoidosis with a focus on cardiac, nervous system, and ocular involvement","volume":"37","author":"Belperio","year":"2021","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jaut.2024.103323_bib6","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.2147\/TCRM.S74476","article-title":"Management of extrapulmonary sarcoidosis: challenges and solutions","volume":"12","author":"Al-Kofahi","year":"2016","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.jaut.2024.103323_bib7","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1056\/NEJMra071714","article-title":"Sarcoidosis","volume":"357","author":"Iannuzzi","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2024.103323_bib8","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1183\/13993003.00457-2016","article-title":"Sarcoidosis-related mortality in France: a multiple-cause-of-death analysis","volume":"48","author":"Jamilloux","year":"2016","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jaut.2024.103323_bib9","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1164\/rccm.201010-1679OC","article-title":"Sarcoidosis-related mortality in the United States from 1988 to 2007","volume":"183","author":"Swigris","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jaut.2024.103323_bib10","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.mayocp.2015.10.024","article-title":"Epidemiology of sarcoidosis 1946-2013: a population-based study","volume":"91","author":"Ungprasert","year":"2016","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.jaut.2024.103323_bib11","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0002-8703(99)70115-8","article-title":"Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies","volume":"138","author":"Uemura","year":"1999","journal-title":"Am. Heart J."},{"key":"10.1016\/j.jaut.2024.103323_bib12","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1136\/heartjnl-2019-316442","article-title":"Cardiac sarcoidosis: state-of-the-art review","volume":"107","author":"Kouranos","year":"2021","journal-title":"Heart"},{"key":"10.1016\/j.jaut.2024.103323_bib13","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1093\/eurheartj\/ehae356","article-title":"Management of cardiac sarcoidosis","volume":"45","author":"Sharma","year":"2024","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.jaut.2024.103323_bib14","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.117.007030","article-title":"Complementary value of cardiac magnetic resonance imaging and positron emission tomography\/computed tomography in the assessment of cardiac sarcoidosis","volume":"11","author":"Vita","year":"2018","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"10.1016\/j.jaut.2024.103323_bib15","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jcmg.2012.10.021","article-title":"CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis","volume":"6","author":"Greulich","year":"2013","journal-title":"JACC Cardiovasc. Imaging"},{"key":"10.1016\/j.jaut.2024.103323_bib16","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.114.011522","article-title":"Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study","volume":"131","author":"Kandolin","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jaut.2024.103323_bib17","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.jcmg.2016.11.019","article-title":"Complementary role of CMR to conventional screening in the diagnosis and prognosis of cardiac sarcoidosis","volume":"10","author":"Kouranos","year":"2017","journal-title":"JACC Cardiovasc. Imaging"},{"key":"10.1016\/j.jaut.2024.103323_bib18","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1378\/chest.07-2784","article-title":"Cardiac involvement in patients with sarcoidosis: diagnostic and prognostic value of outpatient testing","volume":"133","author":"Mehta","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.jaut.2024.103323_bib19","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jacc.2013.09.022","article-title":"Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis","volume":"63","author":"Blankstein","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jaut.2024.103323_bib20","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1161\/CIRCULATIONAHA.109.851352","article-title":"Detection of myocardial damage in patients with sarcoidosis","volume":"120","author":"Patel","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jaut.2024.103323_bib21","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1093\/eurheartj\/ehz428","article-title":"Sudden death in cardiac sarcoidosis: an analysis of nationwide clinical and cause-of-death registries","volume":"40","author":"Ekstrom","year":"2019","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.jaut.2024.103323_bib22","first-page":"19","article-title":"Cardiovascular risks associated with gender and aging","volume":"6","author":"Rodgers","year":"2019","journal-title":"J. Cardiovasc. Dev. Dis."},{"key":"10.1016\/j.jaut.2024.103323_bib23","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/MCP.0000000000000715","article-title":"Sarcoidosis epidemiology: recent estimates of incidence, prevalence and risk factors","volume":"26","author":"Arkema","year":"2020","journal-title":"Curr. Opin. Pulm. Med."},{"key":"10.1016\/j.jaut.2024.103323_bib24","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1183\/13993003.00477-2016","article-title":"Sarcoidosis incidence and prevalence: a nationwide register-based assessment in Sweden","volume":"48","author":"Arkema","year":"2016","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jaut.2024.103323_bib25","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1136\/heartjnl-2022-322243","article-title":"Sex differences in clinical characteristics and prognosis of patients with cardiac sarcoidosis","volume":"109","author":"Iso","year":"2023","journal-title":"Heart"},{"key":"10.1016\/j.jaut.2024.103323_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2021.106564","article-title":"The impact of demographic disparities in the presentation of sarcoidosis: a multicenter prospective study","volume":"187","author":"Zhou","year":"2021","journal-title":"Respir. Med."},{"key":"10.1016\/j.jaut.2024.103323_bib27","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.cardfail.2023.03.022","article-title":"Sex and race differences in cardiac sarcoidosis presentation, treatment and outcomes","volume":"29","author":"Duvall","year":"2023","journal-title":"J. Card. Fail."},{"issue":"9","key":"10.1016\/j.jaut.2024.103323_bib28","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.121.009966","article-title":"Sex differences in patients with suspected cardiac sarcoidosis assessed by cardiovascular magnetic resonance imaging","volume":"14","author":"Kalra","year":"2021","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jaut.2024.103323_bib29","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1378\/chest.10-0413","article-title":"Sarcoidosis in black women in the United States: data from the black women's health study","volume":"139","author":"Cozier","year":"2011","journal-title":"Chest"},{"key":"10.1016\/j.jaut.2024.103323_bib30","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1093\/eurheartj\/ehad067","article-title":"Cardiac sarcoidosis: phenotypes, diagnosis, treatment, and prognosis","volume":"44","author":"Lehtonen","year":"2023","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.jaut.2024.103323_bib31","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis","volume":"11","author":"Birnie","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jaut.2024.103323_bib32","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1164\/rccm.202002-0251ST","volume":"201","author":"Crouser","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jaut.2024.103323_bib33","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1365-2796.2011.02396.x","article-title":"Diagnosing isolated cardiac sarcoidosis","volume":"270","author":"Kandolin","year":"2011","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.jaut.2024.103323_bib34","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1002\/ejhf.3057","article-title":"Predictors of outcome in a contemporary cardiac sarcoidosis population: role of brain natriuretic peptide, left ventricular function and myocardial inflammation","volume":"25","author":"Kouranos","year":"2023","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.jaut.2024.103323_bib35","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1136\/thoraxjnl-2019-214348","article-title":"BTS Clinical Statement on pulmonary sarcoidosis","volume":"76","author":"Thillai","year":"2021","journal-title":"Thorax"},{"key":"10.1016\/j.jaut.2024.103323_bib36","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1161\/CIRCULATIONAHA.121.058120","article-title":"Incidence of sudden cardiac death and life-threatening arrhythmias in clinically manifest cardiac sarcoidosis with and without current indications for an implantable cardioverter defibrillator","volume":"146","author":"Nordenswan","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jaut.2024.103323_bib37","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1253\/circj.CJ-19-0508","article-title":"JCS 2016 guideline on diagnosis and treatment of cardiac sarcoidosis - digest version","volume":"83","author":"Terasaki","year":"2019","journal-title":"Circ. J."},{"key":"10.1016\/j.jaut.2024.103323_bib38","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/jce.12401","article-title":"Atrioventricular block as the initial manifestation of cardiac sarcoidosis in middle-aged adults","volume":"25","author":"Nery","year":"2014","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"10.1016\/j.jaut.2024.103323_bib39","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1378\/chest.106.4.1021","article-title":"Holter monitoring as a noninvasive indicator of cardiac involvement in sarcoidosis","volume":"106","author":"Suzuki","year":"1994","journal-title":"Chest"},{"key":"10.1016\/j.jaut.2024.103323_bib40","first-page":"e272","volume":"138","author":"Al-Khatib","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jaut.2024.103323_bib41","doi-asserted-by":"crossref","DOI":"10.1111\/anec.12864","article-title":"Diagnostic value of implantable loop recorders in patients with unexplained syncope or palpitations","volume":"26","author":"Radovanovi\u0107","year":"2021","journal-title":"Ann. Noninvasive Electrocardiol."},{"key":"10.1016\/j.jaut.2024.103323_bib42","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.hrthm.2021.11.025","article-title":"Long-term monitoring of arrhythmias with cardiovascular implantable electronic devices in patients with cardiac sarcoidosis","volume":"19","author":"Bakker","year":"2022","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jaut.2024.103323_bib43","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1253\/circj.CJ-14-1217","article-title":"Association between basal thinning of interventricular septum and adverse long-term clinical outcomes in patients with cardiac sarcoidosis","volume":"79","author":"Nagano","year":"2015","journal-title":"Circ. J."},{"key":"10.1016\/j.jaut.2024.103323_bib44","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.resinv.2022.02.001","article-title":"Basal interventricular septum thinning and long-term left ventricular function in patients with sarcoidosis","volume":"60","author":"Tanizawa","year":"2022","journal-title":"Respir. Investig."},{"key":"10.1016\/j.jaut.2024.103323_bib45","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12872-019-01323-0","article-title":"Diagnostic and predictive value of speckle tracking echocardiography in cardiac sarcoidosis","volume":"20","author":"Di Stefano","year":"2020","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.jaut.2024.103323_bib46","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1111\/echo.13281","article-title":"Improved detection of myocardial damage in sarcoidosis using longitudinal strain in patients with preserved left ventricular ejection fraction","volume":"33","author":"Murtagh","year":"2016","journal-title":"Echocardiography"},{"key":"10.1016\/j.jaut.2024.103323_bib47","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/ejhf.205","article-title":"Subclinical left ventricular dysfunction by echocardiographic speckle-tracking strain analysis relates to outcome in sarcoidosis","volume":"17","author":"Joyce","year":"2015","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.jaut.2024.103323_bib48","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1536\/ihj.53.287","article-title":"Usefulness of high-sensitive cardiac troponin T for evaluating the activity of cardiac sarcoidosis","volume":"53","author":"Baba","year":"2012","journal-title":"Int. Heart J."},{"key":"10.1016\/j.jaut.2024.103323_bib49","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1536\/ihj.17-695","article-title":"A multiple biomarker approach in patients with cardiac sarcoidosis","volume":"59","author":"Kiko","year":"2018","journal-title":"Int. Heart J."},{"key":"10.1016\/j.jaut.2024.103323_bib50","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ijcard.2004.05.028","article-title":"Detection of cardiac sarcoidosis using cardiac markers and myocardial integrated backscatter","volume":"102","author":"Yasutake","year":"2005","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.jaut.2024.103323_bib51","first-page":"19","article-title":"The WASOG Sarcoidosis Organ Assessment Instrument: an update of a previous clinical tool","volume":"31","author":"Judson","year":"2014","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"10.1016\/j.jaut.2024.103323_bib52","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1001\/jamacardio.2022.2981","article-title":"Cardiovascular magnetic resonance imaging phenotypes and long-term outcomes in patients with suspected cardiac sarcoidosis","volume":"7","author":"Athwal","year":"2022","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jaut.2024.103323_bib53","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/ehjci\/jeac265","article-title":"Cardiac magnetic resonance in giant cell myocarditis: a matched comparison with cardiac sarcoidosis","volume":"24","author":"P\u00f6yh\u00f6nen","year":"2023","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"10.1016\/j.jaut.2024.103323_bib54","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","article-title":"2023 ESC Guidelines for the management of cardiomyopathies","volume":"44","author":"Arbelo","year":"2023","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.jaut.2024.103323_bib55","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.2967\/jnumed.117.196287","article-title":"Joint SNMMI-ASNC expert consensus document on the role of (18)F-FDG PET\/CT in cardiac sarcoid detection and therapy monitoring","volume":"58","author":"Chareonthaitawee","year":"2017","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.jaut.2024.103323_bib56","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/ehjci\/jex146","volume":"18","year":"2017","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"10.1016\/j.jaut.2024.103323_bib57","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2967\/jnumed.111.090662","article-title":"The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the Ontario experience","volume":"53","author":"Youssef","year":"2012","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.jaut.2024.103323_bib58","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s12350-013-9828-6","article-title":"Reduction in (1)(8)F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis","volume":"21","author":"Osborne","year":"2014","journal-title":"J. Nucl. Cardiol."},{"key":"10.1016\/j.jaut.2024.103323_bib59","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1007\/s12149-014-0860-7","article-title":"Right ventricular (18)F-FDG uptake is an important indicator for cardiac involvement in patients with suspected cardiac sarcoidosis","volume":"28","author":"Manabe","year":"2014","journal-title":"Ann. Nucl. Med."},{"key":"10.1016\/j.jaut.2024.103323_bib60","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1007\/s12350-011-9422-8","article-title":"Utility of high fat and low carbohydrate diet in suppressing myocardial FDG uptake","volume":"18","author":"Harisankar","year":"2011","journal-title":"J. Nucl. Cardiol."},{"key":"10.1016\/j.jaut.2024.103323_bib61","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.2967\/jnumed.112.105155","article-title":"SNMMI\/ASNC\/SCCT guideline for cardiac SPECT\/CT and PET\/CT 1.0","volume":"54","author":"Dorbala","year":"2013","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.jaut.2024.103323_bib62","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s12350-016-0502-7","article-title":"Patient preparation for cardiac fluorine-18 fluorodeoxyglucose positron emission tomography imaging of inflammation","volume":"24","author":"Osborne","year":"2017","journal-title":"J. Nucl. Cardiol."},{"key":"10.1016\/j.jaut.2024.103323_bib63","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1007\/s12350-023-03346-9","article-title":"Complete resolution of focal-on-diffuse myocardial activity pattern on FDG PET-CT by prolonging the dietary preparation protocol in cardiac sarcoidosis","volume":"30","author":"Kherajani","year":"2023","journal-title":"J. Nucl. Cardiol."},{"key":"10.1016\/j.jaut.2024.103323_bib64","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s12350-015-0226-0","volume":"23","author":"Manabe","year":"2016","journal-title":"J. Nucl. Cardiol."},{"key":"10.1016\/j.jaut.2024.103323_bib65","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1177\/0284185115600916","article-title":"Administration of unfractionated heparin with prolonged fasting could reduce physiological 18F-fluorodeoxyglucose uptake in the heart","volume":"57","author":"Masuda","year":"2016","journal-title":"Acta Radiol"},{"key":"10.1016\/j.jaut.2024.103323_bib66","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1111\/jce.15191","article-title":"Electrogram-guided endomyocardial biopsy yield in patients with suspected cardiac sarcoidosis and relation to outcomes","volume":"32","author":"Ezzeddine","year":"2021","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"10.1016\/j.jaut.2024.103323_bib67","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.amjcard.2015.01.562","article-title":"Comparison of outcomes in patients with probable versus definite cardiac sarcoidosis","volume":"115","author":"Takaya","year":"2015","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.jaut.2024.103323_bib68","doi-asserted-by":"crossref","first-page":"614","DOI":"10.12968\/hmed.2016.77.11.614","article-title":"Accurate diagnosis of cardiac sarcoidosis needs a multidisciplinary approach","volume":"77","author":"Kouranos","year":"2016","journal-title":"Br. J. Hosp. Med."},{"key":"10.1016\/j.jaut.2024.103323_bib69","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","article-title":"2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"44","author":"McDonagh","year":"2023","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.jaut.2024.103323_bib70","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","article-title":"2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"43","author":"Zeppenfeld","year":"2022","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.jaut.2024.103323_bib71","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.117.006145","article-title":"Outcome of cardiac sarcoidosis presenting with high-grade atrioventricular block","volume":"11","author":"Nordenswan","year":"2018","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"10.1016\/j.jaut.2024.103323_bib72","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.04079-2020","article-title":"ERS clinical practice guidelines on treatment of sarcoidosis","volume":"58","author":"Baughman","year":"2021","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jaut.2024.103323_bib73","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12931-022-01971-5","article-title":"Infliximab therapy in refractory sarcoidosis: a multicenter real-world analysis","volume":"23","author":"Sakkat","year":"2022","journal-title":"Respir. Res."},{"key":"10.1016\/j.jaut.2024.103323_bib74","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.115.003353","article-title":"Time course and factors correlating with ventricular tachyarrhythmias after introduction of steroid therapy in cardiac sarcoidosis","volume":"9","author":"Segawa","year":"2016","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"10.1016\/j.jaut.2024.103323_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.nuclcard.2024.101842","article-title":"Role of serial (18)F-fludeoxyglucose positron emission tomography in determining the therapeutic efficacy of immunosuppression and clinical outcome in patients with cardiac sarcoidosis","author":"Okafor","year":"2024","journal-title":"J. Nucl. Cardiol."},{"key":"10.1016\/j.jaut.2024.103323_bib76","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1002\/joa3.12583","article-title":"Clinical valuables related to resolution of complete or advanced atrioventricular block after steroid therapy in patients with cardiac sarcoidosis","volume":"37","author":"Nabeta","year":"2021","journal-title":"J. Arrhythm."},{"key":"10.1016\/j.jaut.2024.103323_bib77","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.hroo.2021.07.005","article-title":"Management of ventricular tachycardia in patients with cardiac sarcoidosis","volume":"2","author":"Viwe","year":"2021","journal-title":"Heart. Rhythm O2"},{"key":"10.1016\/j.jaut.2024.103323_bib78","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.hrcr.2020.06.028","article-title":"High-dose intravenous glucocorticoids are effective in the acute management of ventricular arrhythmias in cardiac sarcoidosis: a case series","volume":"6","author":"Slivnick","year":"2020","journal-title":"HeartRhythm Case Rep."},{"key":"10.1016\/j.jaut.2024.103323_bib79","first-page":"1","article-title":"Contribution to the question of sarcoid of Boeck and the subcutaneous nodular tuberculid of Darier","volume":"77","author":"Winkler","year":"1905","journal-title":"Arch. Derm. Syph. (Berl)"},{"key":"10.1016\/j.jaut.2024.103323_bib80","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s12883-016-0741-x","article-title":"Clinical features, treatment and outcome in neurosarcoidosis: systematic review and meta-analysis","volume":"16","author":"Fritz","year":"2016","journal-title":"BMC Neurol."},{"key":"10.1016\/j.jaut.2024.103323_bib81","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/B978-0-7020-4086-3.00021-7","article-title":"Neurologic manifestations of sarcoidosis","volume":"119","author":"Krumholz","year":"2014","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.jaut.2024.103323_bib82","first-page":"372","article-title":"Pathological studies on sarcoidosis autopsy, I: epidemiological features of 320 cases in Japan","volume":"43","author":"Iwai","year":"1993","journal-title":"Acta Pathol. Jpn."},{"key":"10.1016\/j.jaut.2024.103323_bib83","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S1474-4422(04)00805-1","article-title":"Neurosarcoidosis: a clinical dilemma","volume":"3","author":"Hoitsma","year":"2004","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jaut.2024.103323_bib84","doi-asserted-by":"crossref","first-page":"336","DOI":"10.7326\/0003-4819-87-3-336","article-title":"Neurologic manifestations in sarcoidosis: review of the literature, with a report of 23 cases","volume":"87","author":"Delaney","year":"1977","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jaut.2024.103323_bib85","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1001\/archneur.1985.04060080095022","article-title":"Sarcoidosis and its neurological manifestations","volume":"42","author":"Stern","year":"1985","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jaut.2024.103323_bib86","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/jnnp.2008.151977","article-title":"Neurosarcoidosis: a study of 30 new cases","volume":"80","author":"Joseph","year":"2009","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jaut.2024.103323_bib87","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00005792-199009000-00001","article-title":"Neurosarcoidosis: signs, course and treatment in 35 confirmed cases","volume":"69","author":"Chapelon","year":"1990","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.jaut.2024.103323_bib88","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1007\/s00415-018-8928-2","article-title":"Sarcoidosis of the central nervous system: clinical features, imaging, and CSF results","volume":"265","author":"Kidd","year":"2018","journal-title":"J. Neurol."},{"key":"10.1016\/j.jaut.2024.103323_bib89","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0889-8529(05)70058-X","article-title":"Differential diagnosis of sellar masses","volume":"28","author":"Freda","year":"1999","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"10.1016\/j.jaut.2024.103323_bib90","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1093\/qjmed\/hcs121","article-title":"Hypothalamo-pituitary sarcoidosis: a multicenter study of 24 patients","volume":"105","author":"Langrand","year":"2012","journal-title":"QJM"},{"key":"10.1016\/j.jaut.2024.103323_bib91","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/MD.0b013e31815585aa","article-title":"Sarcoidosis: clinical, hormonal, and magnetic resonance imaging (MRI) manifestations of hypothalamic-pituitary disease in 9 patients and review of the literature","volume":"86","author":"Bihan","year":"2007","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.jaut.2024.103323_bib92","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/qjmed\/hcp042","article-title":"Presentations and outcomes of neurosarcoidosis: a study of 54 cases","volume":"102","author":"Pawate","year":"2009","journal-title":"QJM"},{"key":"10.1016\/j.jaut.2024.103323_bib93","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/ccr3.2665","article-title":"Hydrocephalus as the presenting symptom of sarcoidosis: a case report and review of literature","volume":"8","author":"Saban","year":"2020","journal-title":"Clin. Case Rep."},{"key":"10.1016\/j.jaut.2024.103323_bib94","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1212\/WNL.43.2.333","article-title":"Intramedullary spinal sarcoidosis: clinical and magnetic resonance imaging characteristics","volume":"43","author":"Junger","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2024.103323_bib95","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001170","article-title":"Neurosarcoidosis of the cauda equina: clinical course, radiographic and electrodiagnostic findings, response to treatment, and outcomes","volume":"9","author":"Bou","year":"2022","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.jaut.2024.103323_bib96","doi-asserted-by":"crossref","first-page":"589","DOI":"10.7326\/0003-4819-88-5-589","article-title":"Hypothalamic insufficiency: the cause of hypopituitarism in sarcoidosis","volume":"88","author":"Stuart","year":"1978","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jaut.2024.103323_bib97","first-page":"254","article-title":"\u00dcber eine \u2018Febris uveoparotidea subchronica\u2019 an der Glandula parotis der Uvea des Auges lokalisiert und h\u00e4ufig mit Paresen cerebrospinaler Nerver kompliziert","volume":"70","author":"Heerfordt","year":"1909","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.jaut.2024.103323_bib98","doi-asserted-by":"crossref","first-page":"5328","DOI":"10.1007\/s00415-022-11189-6","article-title":"Facial nerve palsy in neurosarcoidosis: clinical course, neuroinflammatory accompaniments, ancillary investigations, and response to treatment","volume":"269","author":"Nwebube","year":"2022","journal-title":"J. Neurol."},{"key":"10.1016\/j.jaut.2024.103323_bib99","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1212\/WNL.41.10.1558","article-title":"Sarcoid peripheral neuropathy","volume":"41","author":"Zuniga","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2024.103323_bib100","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/mus.21890","article-title":"Sarcoidosis presenting as acute inflammatory demyelinating polyradiculoneuropathy","volume":"43","author":"Saifee","year":"2011","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jaut.2024.103323_bib101","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1016\/S0140-6736(02)08912-2","article-title":"Small fiber neuropathy in sarcoidosis","volume":"359","author":"Hoitsma","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2024.103323_bib102","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.rmed.2017.03.011","article-title":"Sarcoidosis-associated small fiber neuropathy in a large cohort: clinical aspects and response to IVIG and anti-TNF alpha treatment","volume":"126","author":"Tavee","year":"2017","journal-title":"Respir. Med."},{"key":"10.1016\/j.jaut.2024.103323_bib103","article-title":"Sarcoidosis and pain caused by small-fiber neuropathy","volume":"2012","author":"Heij","year":"2012","journal-title":"Pain Res. Treat."},{"key":"10.1016\/j.jaut.2024.103323_bib104","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.diii.2014.11.038","article-title":"Multimodality evaluation of musculoskeletal sarcoidosis: imaging findings and literature review","volume":"97","author":"Aptel","year":"2016","journal-title":"Diagn. Interv. Imaging"},{"key":"10.1016\/j.jaut.2024.103323_bib105","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1016\/S0140-6736(12)60683-7","article-title":"A tiger man","volume":"380","author":"Wie\u00ebrs","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2024.103323_bib106","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11926-019-0806-0","article-title":"Radiologic manifestations of musculoskeletal sarcoidosis","volume":"21","author":"Brand\u00e3o Guimar\u00e3es","year":"2019","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.jaut.2024.103323_bib107","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1148\/rg.2018180053","article-title":"PET\/CT in the diagnosis and workup of sarcoidosis: focus on atypical manifestations","volume":"38","author":"Akaike","year":"2018","journal-title":"Radiographics"},{"key":"10.1016\/j.jaut.2024.103323_bib108","first-page":"185","article-title":"Neurosarcoidosis: evaluation with MRI","volume":"27","author":"Pickuth","year":"2000","journal-title":"J. Neuroradiol."},{"key":"10.1016\/j.jaut.2024.103323_bib109","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1007\/s00415-010-5623-3","article-title":"Soluble CSF interleukin 2 receptor as indicator of neurosarcoidosis","volume":"257","author":"Petereit","year":"2010","journal-title":"J. Neurol."},{"key":"10.1016\/j.jaut.2024.103323_bib110","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1001\/jamaneurol.2013.606","article-title":"A systematic approach to the diagnosis of suspected central nervous system lymphoma","volume":"70","author":"Scott","year":"2013","journal-title":"JAMA Neurol."},{"issue":"Suppl 124","key":"10.1016\/j.jaut.2024.103323_bib111","first-page":"135","article-title":"Differentiation between neurosarcoidosis and primary central nervous system vasculitis based on demographic, cerebrospinal and imaging features","volume":"38","author":"Saygin","year":"2020","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jaut.2024.103323_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2021.117531","article-title":"Neuroimaging findings in rheumatological disorders","volume":"427","author":"Kandemirli","year":"2021","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jaut.2024.103323_bib113","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2021.117420","article-title":"The neurology of IgG4-related disease","volume":"424","author":"Saitakis","year":"2021","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jaut.2024.103323_bib114","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.rdc.2017.06.008","volume":"43","author":"Ungprasert","year":"2017","journal-title":"Neurosarcoidosis. Rheum. Dis. Clin. North Am."},{"key":"10.1016\/j.jaut.2024.103323_bib115","doi-asserted-by":"crossref","first-page":"e331","DOI":"10.1016\/j.lpm.2011.12.017","article-title":"Neurosarcoidosis: clinical manifestations, diagnosis and treatment","volume":"41","author":"Nozaki","year":"2012","journal-title":"Presse Med."},{"key":"10.1016\/j.jaut.2024.103323_bib116","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1001\/archneur.64.5.691","article-title":"Aggressive therapy for neurosarcoidosis: long-term follow-up of 48 treated patients","volume":"64","author":"Scott","year":"2007","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jaut.2024.103323_bib117","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1001\/archinte.1997.00440370104011","article-title":"Diagnosis and management of neurological sarcoidosis","volume":"157","author":"Lower","year":"1997","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.jaut.2024.103323_bib118","doi-asserted-by":"crossref","DOI":"10.1177\/1756286418805732","article-title":"Successful therapy with rituximab in three patients with probable neurosarcoidosis","volume":"11","author":"Zella","year":"2018","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.jaut.2024.103323_bib119","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/WCO.0000000000000684","article-title":"Management of neurosarcoidosis: a clinical challenge","volume":"32","author":"Voortman","year":"2019","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.jaut.2024.103323_bib120","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1136\/jnnp.2008.149989","article-title":"Treatment of refractory neurosarcoidosis with Infliximab","volume":"81","author":"Santos","year":"2010","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jaut.2024.103323_bib121","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1212\/WNL.0000000000004644","article-title":"Infliximab for the treatment of CNS sarcoidosis: a multi-institutional series","volume":"89","author":"Gelfand","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2024.103323_bib122","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s00415-017-8444-9","article-title":"Long-term outcomes of refractory neurosarcoidosis treated with infliximab","volume":"264","author":"Cohen Aubart","year":"2017","journal-title":"J. Neurol."},{"key":"10.1016\/j.jaut.2024.103323_bib123","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1016\/j.ejim.2011.08.019","article-title":"Neurosarcoidosis: report of 30 cases and a literature survey","volume":"22","author":"Gasc\u00f3n-Bayarri","year":"2011","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.jaut.2024.103323_bib124","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1001\/jamaneurol.2017.2492","article-title":"Association of prognostic factors and immunosuppressive treatment with long-term outcomes in neurosarcoidosis","volume":"74","author":"Joubert","year":"2017","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jaut.2024.103323_bib125","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1136\/bjo.45.7.461","article-title":"The eyes in sarcoidosis","volume":"45","author":"Pitts Crick","year":"1961","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.jaut.2024.103323_bib126","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1080\/09273948.2017.1386791","article-title":"Clinical characteristics of ocular sarcoidosis: a population-based study 1976-2013","volume":"27","author":"Ungprasert","year":"2019","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.jaut.2024.103323_bib127","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/IIO.0000000000000069","article-title":"Ocular sarcoidosis","volume":"55","author":"Patel","year":"2015","journal-title":"Int. Ophthalmol. Clin."},{"key":"10.1016\/j.jaut.2024.103323_bib128","first-page":"119","article-title":"The clinical course of sarcoidosis: presentation, diagnosis, and treatment in a large white and black cohort in the United States","volume":"29","author":"Judson","year":"2012","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"10.1016\/j.jaut.2024.103323_bib129","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1055\/s-0037-1602382","article-title":"Ocular involvement in sarcoidosis","volume":"38","author":"Groen","year":"2017","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"10.1016\/j.jaut.2024.103323_bib130","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ajo.2018.09.013","article-title":"Sarcoidosis-related uveitis: clinical presentation, disease course, and rates of systemic disease progression after uveitis diagnosis","volume":"198","author":"Ma","year":"2019","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.jaut.2024.103323_bib131","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ophtha.2006.05.074","article-title":"Differences in clinical findings between Caucasians and African Americans with biopsy-proven sarcoidosis","volume":"114","author":"Evans","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaut.2024.103323_bib132","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000321947","article-title":"The eye as a common site for the early clinical manifestation of sarcoidosis","volume":"46","author":"Heiligenhaus","year":"2011","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.jaut.2024.103323_bib133","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2024.107562","article-title":"Role of screening for uveitis in subjects with sarcoidosis","volume":"224","author":"Koh","year":"2024","journal-title":"Respir. Med."},{"key":"10.1016\/j.jaut.2024.103323_bib134","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/S0161-6420(96)30417-X","article-title":"Prognosticators for visual outcome in sarcoid uveitis","volume":"103","author":"Dana","year":"1996","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaut.2024.103323_bib135","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1755-3768.2008.01282.x","article-title":"Clinical features of intraocular inflammation in Hokkaido, Japan","volume":"87","author":"Kitamei","year":"2009","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.jaut.2024.103323_bib136","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/s10384-012-0158-z","article-title":"The 2009 prospective multi-center epidemiologic survey of uveitis in Japan","volume":"56","author":"Ohguro","year":"2012","journal-title":"Jpn. J. Ophthalmol."},{"key":"10.1016\/j.jaut.2024.103323_bib137","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10384-006-0383-4","article-title":"Epidemiological survey of intraocular inflammation in Japan","volume":"51","author":"Goto","year":"2007","journal-title":"Jpn. J. Ophthalmol."},{"key":"10.1016\/j.jaut.2024.103323_bib138","doi-asserted-by":"crossref","first-page":"889","DOI":"10.2147\/OPTH.S80972","article-title":"Epidemiology of uveitis in the mid-Atlantic United States","volume":"9","author":"Bajwa","year":"2015","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.jaut.2024.103323_bib139","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3899\/jrheum.080102","article-title":"Uveitis subtypes in a German interdisciplinary uveitis center\u2013analysis of 1916 patients","volume":"36","author":"Jakob","year":"2009","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jaut.2024.103323_bib140","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1750-1172-7-57","article-title":"Uveitis- a rare disease often associated with systemic diseases and infections- a systematic review of 2619 patients","volume":"7","author":"Barisani-Asenbauer","year":"2012","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.jaut.2024.103323_bib141","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3109\/09273948.2013.855799","article-title":"The Manchester Uveitis Clinic: the first 3000 patients\u2013 epidemiology and casemix","volume":"23","author":"Jones","year":"2015","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.jaut.2024.103323_bib142","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/aos.12675","article-title":"Epidemiology of uveitis in a Western urban multiethnic population. The challenge of globalization","volume":"93","author":"Lloren\u00e7","year":"2015","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.jaut.2024.103323_bib143","article-title":"Changes in patterns of uveitis at a tertiary referral center in Northern Italy: analysis of 990 consecutive cases","volume":"38","author":"Cimino","year":"2018","journal-title":"Int. Ophthalmol."},{"key":"10.1016\/j.jaut.2024.103323_bib144","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/aos.14130","article-title":"Epidemiology of uveitis in a region of southern Sweden","volume":"98","author":"Bro","year":"2020","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.jaut.2024.103323_bib145","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2019.102351","article-title":"Uveitis: autoimmunity and beyond","volume":"18","author":"Bertrand","year":"2019","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2024.103323_bib146","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/ICU.0000000000000704","article-title":"An update on the diagnosis and management of ocular sarcoidosis","volume":"31","author":"Hwang","year":"2020","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.jaut.2024.103323_bib147","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.2147\/OPTH.S72383","article-title":"Characteristics of uveitic glaucoma and evaluation of its surgical treatment","volume":"8","author":"Shimizu","year":"2014","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.jaut.2024.103323_bib148","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.3390\/jcm12093194","article-title":"Sarcoidosis-related uveitis: a review","volume":"12","author":"Giorgiutti","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jaut.2024.103323_bib149","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1136\/bjo.84.1.110","article-title":"Ocular involvement in sarcoidosis","volume":"84","author":"Rothova","year":"2000","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.jaut.2024.103323_bib150","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1136\/bjophthalmol-2018-313356","article-title":"Revised criteria of international Workshop on ocular sarcoidosis (IWOS) for the diagnosis of ocular sarcoidosis","volume":"103","author":"Mochizuki","year":"2019","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.jaut.2024.103323_bib151","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ajo.2021.03.047","article-title":"Classification criteria for sarcoidosis-associated uveitis","volume":"228","year":"2021","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.jaut.2024.103323_bib152","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1001\/jama.2019.12618","article-title":"FAST Research Group. Effect of corticosteroid-sparing treatment with mycophenolate mofetil vs methotrexate on inflammation in patients with uveitis: a randomized clinical trial","volume":"322","author":"Rathinam","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jaut.2024.103323_bib153","article-title":"Methotrexate versus conventional disease-modifying antirheumatic drugs in the treatment of non-anterior sarcoidosis-associated uveitis","volume":"16","author":"Leclercq","year":"2024","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.jaut.2024.103323_bib154","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJMoa1509852","article-title":"Adalimumab in patients with active noninfectious uveitis","volume":"375","author":"Jaffe","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2024.103323_bib155","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S0140-6736(16)31339-3","article-title":"Adalimumab for prevention of uveitic flare in patients with inactive noninfectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial","volume":"388","author":"Nguyen","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2024.103323_bib156","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/S0012-3692(15)50471-6","article-title":"Etanercept for refractory ocular sarcoidosis: results of a double-blind randomized trial","volume":"128","author":"Baughman","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.jaut.2024.103323_bib157","first-page":"43","article-title":"Leflunomide for chronic sarcoidosis","volume":"21","author":"Baughman","year":"2004","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"10.1016\/j.jaut.2024.103323_bib158","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S0954-6111(03)00127-6","article-title":"Cutaneous involvement in sarcoidosis: analysis of the features in 170 patients","volume":"97","author":"Yanarda\u011f","year":"2003","journal-title":"Respir. Med."},{"key":"10.1016\/j.jaut.2024.103323_bib159","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1684\/ejd.2015.2666","article-title":"Prognostic value of skin lesions in sarcoidosis: clinical and histopathological clues","volume":"25","author":"Esteves","year":"2015","journal-title":"Eur. J. Dermatol."},{"key":"10.1016\/j.jaut.2024.103323_bib160","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/j.1365-2230.2011.04128.x","article-title":"Specific cutaneous lesions in patients with systemic sarcoidosis. Relationship to severity and chronicity of disease","volume":"36","author":"Marcoval","year":"2011","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.jaut.2024.103323_bib161","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1164\/rccm.200807-1082OC","article-title":"Lofgren's syndrome: human Leukocyte antigen strongly influences the disease course","volume":"179","author":"Grunewald","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jaut.2024.103323_bib162","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2020.105998","article-title":"Clinical features and outcomes of asymptomatic pulmonary sarcoidosis. A comparative cohort study","volume":"169","author":"Iriarte","year":"2020","journal-title":"Respir. Med."},{"key":"10.1016\/j.jaut.2024.103323_bib163","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jaad.2011.11.965","article-title":"Sarcoidosis: a comprehensive review and update for the dermatologist","volume":"66","author":"Haimovic","year":"2012","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jaut.2024.103323_bib164","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/j.1365-2230.2011.04128.x","article-title":"Specific cutaneous lesions in patients with systemic sarcoidosis. Relationship to severity and chronicity of disease","volume":"36","author":"Marcoval","year":"2011","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.jaut.2024.103323_bib165","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01160-2020","article-title":"Clinical phenotypes of extrapulmonary sarcoidosis: an analysis of a French, multi-ethnic, multicentre cohort","volume":"57","author":"Lhote","year":"2021","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jaut.2024.103323_bib166","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1378\/chest.08-1347","article-title":"The treatment of lupus pernio: results of 116 treatment courses in 54 patients","volume":"135","author":"Stagaki","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.jaut.2024.103323_bib167","article-title":"Subcutaneous sarcoidosis in a rhinoplasty scar","volume":"2015","author":"Dulguerov","year":"2015","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.jaut.2024.103323_bib168","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/DAD.0000000000000928","article-title":"Specific skin lesions of sarcoidosis located at venipuncture points for blood sample collection","volume":"40","author":"Marcoval","year":"2018","journal-title":"Am. J. Dermopathol."},{"key":"10.1016\/j.jaut.2024.103323_bib169","first-page":"427","article-title":"Foreign bodies in granulomatous cutaneous lesions of patients with systemic sarcoidosis","volume":"137","author":"Marcoval","year":"2001","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.jaut.2024.103323_bib170","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1111\/jdv.12338","article-title":"Systemic sarcoidosis with specific cutaneous lesions located at insulin injection site for diabetes mellitus","volume":"28","author":"Marcoval","year":"2014","journal-title":"J. Eur. Acad. Dermatol. Veneorol."},{"key":"10.1016\/j.jaut.2024.103323_bib171","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/ced.12262","article-title":"Sarcoidosis associated with cosmetic fillers","volume":"39","author":"Marcoval","year":"2014","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.jaut.2024.103323_bib172","first-page":"485","article-title":"The presence of foreign bodies does not exclude the diagnosis of sarcoidosis","volume":"137","author":"Callen","year":"2001","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.jaut.2024.103323_bib173","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1001\/jamadermatol.2013.60","article-title":"Reliability and convergent validity of the cutaneous sarcoidosis activity and morphology instrument for assessing cutaneous sarcoidosis","volume":"149","author":"Rosenbach","year":"2013","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.jaut.2024.103323_bib174","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/jamadermatol.2015.2008","article-title":"Reliability and validity of cutaneous sarcoidosis outcome instruments among dermatologists, pulmonologists, and rheumatologists","volume":"151","author":"Yeung","year":"2015","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.jaut.2024.103323_bib175","first-page":"165","article-title":"Inter-rater reliability of cutaneous sarcoidosis assessment tools via remote photographic assessment","volume":"34","author":"Berg","year":"2017","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"10.1016\/j.jaut.2024.103323_bib176","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2165\/00128071-200809030-00003","article-title":"Chronic facial sarcoidosis including lupus pernio: clinical description and proposed scoring systems","volume":"9","author":"Baughman","year":"2008","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.jaut.2024.103323_bib177","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.ccm.2015.08.010","article-title":"Cutaneous sarcoidosis","volume":"36","author":"Wanat","year":"2015","journal-title":"Clin. Chest Med."},{"key":"10.1016\/j.jaut.2024.103323_bib178","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1365-2230.2007.02397.x","article-title":"Topical tacrolimus for the treatment of cutaneous sarcoidosis","volume":"32","author":"Green","year":"2007","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.jaut.2024.103323_bib179","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jdcr.2020.11.016","article-title":"Treatment of angiolupoid sarcoidosis with tofacitinib ointment 2% and pulsed dye laser therapy","volume":"7","author":"Singh","year":"2020","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.jaut.2024.103323_bib180","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jdcr.2021.08.012","article-title":"Treatment of cutaneous sarcoidosis with tofacitinib: a case report and review of evidence for Janus kinase inhibition in sarcoidosis","volume":"16","author":"Talty","year":"2021","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.jaut.2024.103323_bib181","first-page":"1","article-title":"Treatment of cutaneous sarcoidosis with tofacitinib 2% ointment and extra virgin olive oil","volume":"9","author":"Alam","year":"2020","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.jaut.2024.103323_bib182","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/j.1524-4725.2009.01202.x","article-title":"Successful treatment of cutaneous sarcoidosis lesions with the flashlamp pumped pulsed dye laser: a case report","volume":"35","author":"Roos","year":"2009","journal-title":"Dermatol. Surg."},{"key":"10.1016\/j.jaut.2024.103323_bib183","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1080\/09546630410023584","article-title":"Recalcitrant cutaneous sarcoidosis: an evidence-based sequential approach","volume":"15","author":"Mosam","year":"2004","journal-title":"J. Dermatolog. Treat."},{"key":"10.1016\/j.jaut.2024.103323_bib184","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1001\/archderm.137.1.69","article-title":"The use of tetracyclines for the treatment of sarcoidosis","volume":"137","author":"Bachelez","year":"2001","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.jaut.2024.103323_bib185","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1001\/jamadermatol.2013.2977","article-title":"Oral minocycline in treatment of cutaneous sarcoidosis","volume":"149","author":"Steen","year":"2013","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.jaut.2024.103323_bib186","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1164\/ajrccm.155.5.9154873","article-title":"Pentoxifylline in treatment of sarcoidosis","volume":"155","author":"Zabel","year":"1997","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jaut.2024.103323_bib187","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1001\/archdermatol.2011.301","article-title":"Efficacy and safety of apremilast in chronic cutaneous sarcoidosis","volume":"148","author":"Baughman","year":"2012","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.jaut.2024.103323_bib188","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1001\/archderm.1983.01650360049012","article-title":"Treatment of cutaneous sarcoidosis with isotretinoin","volume":"119","author":"Waldinger","year":"1983","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.jaut.2024.103323_bib189","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00000441-199003000-00002","article-title":"The use of low dose methotrexate in refractory sarcoidosis","volume":"299","author":"Lower","year":"1990","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.jaut.2024.103323_bib190","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1001\/archinte.1995.00430080088011","article-title":"Prolonged use of methotrexate for sarcoidosis","volume":"155","author":"Lower","year":"1995","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.jaut.2024.103323_bib191","first-page":"60","article-title":"Methotrexate is steroid sparing in acute sarcoidosis: results of a double blind, randomized trial","volume":"17","author":"Baughman","year":"2000","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"10.1016\/j.jaut.2024.103323_bib192","doi-asserted-by":"crossref","DOI":"10.1016\/j.pupt.2019.101840","article-title":"Mycophenolate mofetil as an alternative treatment in sarcoidosis","volume":"58","author":"Papiris","year":"2019","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.jaut.2024.103323_bib193","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/j.rmed.2014.09.013","article-title":"Efficacy of mycophenolate mofetil in sarcoidosis","volume":"108","author":"Hamzeh","year":"2014","journal-title":"Respir. Med."},{"key":"10.1016\/j.jaut.2024.103323_bib194","first-page":"43","article-title":"Leflunomide for chronic sarcoidosis","volume":"21","author":"Baughman","year":"2004","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"10.1016\/j.jaut.2024.103323_bib195","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jaad.2003.07.006","article-title":"Treatment of cutaneous sarcoidosis with thalidomide","volume":"50","author":"Nguyen","year":"2004","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jaut.2024.103323_bib196","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1378\/chest.14-0015","article-title":"A randomized, investigator-masked, double-blind, placebo-controlled trial on thalidomide in severe cutaneous sarcoidosis","volume":"146","author":"Droitcourt","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.jaut.2024.103323_bib197","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/ajd.12056","article-title":"Cutaneous sarcoidosis and infliximab: evidence for efficacy in refractory disease","volume":"55","author":"Tu","year":"2014","journal-title":"Australas. J. Dermatol."},{"key":"10.1016\/j.jaut.2024.103323_bib198","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s13555-012-0011-9","article-title":"A case series of refractory cutaneous sarcoidosis successfully treated with infliximab","volume":"2","author":"Tuchinda","year":"2012","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.jaut.2024.103323_bib199","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1001\/archdermatol.2012.1322","article-title":"Case series demonstrating improvement in chronic cutaneous sarcoidosis following treatment with TNF inhibitors","volume":"148","author":"Wanat","year":"2012","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.jaut.2024.103323_bib200","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1001\/archdermatol.2011.307","article-title":"Successful treatment of lupus pernio with adalimumab","volume":"147","author":"Judson","year":"2011","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.jaut.2024.103323_bib201","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.jaad.2012.10.056","article-title":"A double-blind, randomized, placebo- controlled trial of adalimumab in the treatment of cutaneous sarcoidosis","volume":"68","author":"Pariser","year":"2013","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jaut.2024.103323_bib202","first-page":"289","article-title":"Infliximab for chronic cutaneous sarcoidosis: a subset analysis from a double-blind randomized clinical trial","volume":"32","author":"Baughman","year":"2016","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"10.1016\/j.jaut.2024.103323_bib203","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1183\/09031936.00000914","article-title":"Safety and efficacy of ustekinumab or golimumab in patients with chronic sarcoidosis","volume":"44","author":"Judson","year":"2014","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jaut.2024.103323_bib204","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.2169\/internalmedicine.47.0602","article-title":"Development of sarcoidosis during etanercept therapy","volume":"47","author":"Ishiguro","year":"2008","journal-title":"Intern. Med."},{"key":"10.1016\/j.jaut.2024.103323_bib205","doi-asserted-by":"crossref","first-page":"e583","DOI":"10.1111\/jdv.16451","article-title":"Development or worsening of sarcoidosis associated with IL-17 blockade for psoriasis","volume":"34","author":"Hornick","year":"2020","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.jaut.2024.103323_bib206","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1056\/NEJMoa1805958","article-title":"Tofacitinib treatment and molecular analysis of cutaneous sarcoidosis","volume":"379","author":"Damsky","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2024.103323_bib207","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/acr2.11112","article-title":"Treatment of multiorgan sarcoidosis with tofacitinib","volume":"2","author":"Damsky","year":"2020","journal-title":"ACR Open Rheumatol"},{"key":"10.1016\/j.jaut.2024.103323_bib208","first-page":"1","article-title":"Treatment of cutaneous sarcoidosis with tofacitinib 2% ointment and extra virgin olive oil","volume":"9","author":"Alam","year":"2020","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.jaut.2024.103323_bib209","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.jaad.2019.05.098","article-title":"Janus kinase inhibition induces disease remission in cutaneous sarcoidosis and granuloma annulare","volume":"82","author":"Damsky","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jaut.2024.103323_bib210","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1038\/s41467-022-30615-x","article-title":"Inhibition of type 1 immunity with tofacitinib is associated with marked improvement in longstanding sarcoidosis","volume":"13","author":"Damsky","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jaut.2024.103323_bib211","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.jdcr.2019.02.006","article-title":"Resolution of cutaneous sarcoidosis after Janus kinase inhibitor therapy for concomitant polycythemia vera","volume":"5","author":"Wei","year":"2019","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.jaut.2024.103323_bib212","article-title":"Dramatic response of refractory sarcoidosis under ruxolitinib in a patient with associated JAK2-mutated polycythemia","volume":"20","author":"Rotenberg","year":"2018","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jaut.2024.103323_bib213","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1016\/S2665-9913(23)00302-8","article-title":"Efficacy and safety of mTOR inhibition in cutaneous sarcoidosis: a single-centre trial","volume":"6","author":"Redl","year":"2024","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.jaut.2024.103323_bib214","doi-asserted-by":"crossref","DOI":"10.1016\/j.xjidi.2023.100220","article-title":"Molecularly targeted therapies for inflammatory cutaneous granulomatous disorders","volume":"3","author":"Hwang","year":"2023","journal-title":"JID Innov."},{"key":"10.1016\/j.jaut.2024.103323_bib215","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.100966","article-title":"Extrapulmonary sarcoidosis with a focus on cardiac, nervous system, and ocular involvement","volume":"37","author":"Belperio","year":"2021","journal-title":"EClinicalMedicine"},{"issue":"Supplement_6","key":"10.1016\/j.jaut.2024.103323_bib216","doi-asserted-by":"crossref","first-page":"S445","DOI":"10.1513\/AnnalsATS.201707-567OT","article-title":"Application of \u201comics\u201d and systems biology to sarcoidosis research","volume":"14","author":"Crouser","year":"2017","journal-title":"Ann. Am. Thorac. Soc."},{"key":"10.1016\/j.jaut.2024.103323_bib217","doi-asserted-by":"crossref","first-page":"390","DOI":"10.3390\/jcm9020390","article-title":"Comprehensive care for patients with sarcoidosis","volume":"9","author":"Moor","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jaut.2024.103323_bib218","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/1753465816686743","article-title":"Optimizing quality of life in patients with idiopathic pulmonary fibrosis","volume":"11","author":"van Manen","year":"2017","journal-title":"Ther. Adv. Respir. Dis."},{"key":"10.1016\/j.jaut.2024.103323_bib219","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/S2213-2600(17)30383-1","article-title":"Palliative care in interstitial lung disease: living well","volume":"5","author":"Kreuter","year":"2017","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.jaut.2024.103323_bib220","doi-asserted-by":"crossref","first-page":"4605","DOI":"10.1007\/s12325-021-01832-5","article-title":"How to tackle the diagnosis and treatment in the diverse scenarios of extrapulmonary sarcoidosis","volume":"38","author":"Valeyre","year":"2021","journal-title":"Adv. Ther."},{"key":"10.1016\/j.jaut.2024.103323_bib221","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.chest.2020.01.026","article-title":"Association of medication adherence and clinical outcomes in sarcoidosis","volume":"158","author":"Sharp","year":"2020","journal-title":"Chest"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841124001574?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841124001574?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T06:41:57Z","timestamp":1738478517000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841124001574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":221,"alternative-id":["S0896841124001574"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2024.103323","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extrapulmonary sarcoidosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2024.103323","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103323"}}